Cansino Biologics Inc (688185.SS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE100004BM0
Cansino Biologics Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 846.34 m CNY | 1.07 bn CNY |
| Gross profit | 583.58 m CNY | 1.07 bn CNY |
| Operating income | -375.22 m CNY | 23.91 m CNY |
| EBIT | -321.05 m CNY | 21.74 m CNY |
| Net income | -378.88 m CNY | 27.87 m CNY |
| Diluted EPS – continuing operations | -1.53 CNY | 0.11 CNY |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Cansino Biologics Inc
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. In addition, it develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; and TB Booster for the BCG-vaccinated population which is in Phase I clinical trial. Further, it is developing various preclinical stage products, including DTcP-Hib Combo vaccine; and CS-2023 to treat meningitis. The company was incorporated in 2009 and is headquartered in Tianjin, the People's Republic of China.
More stocks
- Skshu Paint Co Ltd (603737.SS)
- GROUP 1 AUTOMOTIVE INC (GPI)
- Arcplus Group PLC (600629.SS)
- NEWMARK GROUP, INC. (NMRK)
- Hochschild Mining PLC (HOC.L)
- Auren Energia S.A. (AURE3.SA)
- Construcciones y Auxiliar de Ferrocarriles SA (CAF.MC)
- Dyne Therapeutics, Inc. (DYN)
- Bumi Resources Tbk (BUMI.JK)
- North Industries Group Red Arrow Co Ltd (000519.SZ)
- IGB Real Estate Investment Trust (5227.KL)
- Xiamen Kehua Hengsheng (002335.SZ)
Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.